Latin American Human Papillomavirus Symposium April 2018 Catholic Argentine University Auditorium Buenos Aires Argentina. Preliminary Program

Similar documents
Implementing Standards in Training in Latin America

The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Women s Cancer Initiative: A joint commitment to save lives AGENDA

Human Papillomavirus (HPV) in Patients with HIV.

Information on: HPV testing. jostrust.org.uk

REVIEW OF SCREENING RECOMMENDATIONS FROM AROUND THE WORLD LATIN AMERICA

The implications of HPV immunisation on cervical screening

Primary High Risk HPV Testing with Cytology Triage

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Objectives. HPV Classification. The Connection Between Human Papillomavirus and Oropharyngeal Cancer 6/19/2012

Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage

HPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II

CERVICAL CANCER FACTSHEET. What is cervical cancer?

papillomavirus Educational workshop the International MAY MALMÖ, SWEDEN International Papillomavirus Conference 25th

Update of the role of Human Papillomavirus in Head and Neck Cancer

EACS HIV Summer School PRELIMINARY PROGRAMME

HPV vaccination Where are we now? Where are we going? Margaret Stanley Department of Pathology Cambridge

XIV Anual Scientific Meeting I International Meeting Argentine Society of Lipids - International Atherosclerosis Society

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition

Epidemiologia dell HPV e cancro della cervice nel mondo. Silvia Franceschi

Faculty of Pathology 36th Annual Symposium & Annual General Meeting

Sao Paulo, Brazil April 10-12, :30-10 a.m. Current Trends and Challenges on Dementia Practice in Latin America Ricardo Nitrini (Brazil)

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

9th INTERNATIONAL NICE September, 2018 Milan, Italy. Islet - beta cell. replacement

HPV Vaccine Safety & Effectiveness

Trends in HPV-Associated Cancers United States,

Third meeting of the Technical Cooperation Group on SDG4- Education 2030 Indicators (TCG) Agenda

Healthcare providers HPV vaccination recommendation practices in Argentina, Malaysia, South Africa, South Korea, and Spain

HUMAN PAPILLOMAVIRUS. About Human papillomavirus

Human Papillomavirus

HPV infections and potential outcomes

The successful case of HPV prophylactic vaccines

EXPOSING DANGERS OF HUMAN PAPILLOMAVIRUS IN BOTH MEN AND WOMEN

Understanding Your Pap Test Results

Target audience. Jorge Correale Department of Neurology Raúl Carrea Institute for Neurological Research (FLENI) Buenos Aires, Argentina

Immunise against HPV

ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain

Towards the elimination of HPV

Preliminary Programme

PRELIMINARY PROGRAMME NHOW MILAN

The Early Nutrition Academy (ENA) was established in the context of sustainability actions of

Human Papillomavirus Lafayette Medical Education Foundation June 19, 2018

The Biology of HPV Infection and Cervical Cancer

The promise of HPV vaccines for Cervical (and other genital cancer) prevention

Global HPV Disease Burden : Rationale for Vaccine

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Dear Professor, On behalf of the Symposium Organizing Committees, it gives us great pleasure to invite you and all the teachers and students of your

Arg-ADNI. WW-ADNI update, Boston, July 12, 2013

IUGA REGIONAL SYMPOSIUM December 12-13, 2011 Sao Paulo, Brazil Federal University of Sao Paulo PRELIMINARY PROGRAM. Regional

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Supplementary Appendix

VACCINOLOGY RESEARCH SYMPOSIUM In celebration of Dr. David Scheifele s Research Career

Cervical Cancer Screening

TRAINING COURSE PROPOSAL. IAEA TC Project RER/1/011 Introducing and Harmonizing Standardized Procedures for Radiation Technologies

R. Sankaranarayanan MD

INVASIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA INCIDENCE RATE* MISSISSIPPI,

HIV and AIDS Related Cancers DR GORDON AMBAYO UHS

Preventing human papillomavirus (HPV) cancers and diseases by vaccination

HPV-Associated Disease and Prevention

Vaccine administration. Dr Brenda Corcoran National Immunisation Office

- ii - Rights c

EUROGIN CERVICAL CANCER PREVENTION: 20 YEARS OF PROGRESS AND A PATH TO THE FUTURE Monte-Carlo (Monaco) Grimaldi Forum February 17-20, 2010

Workshop: Proctological and Pelvic Floor Disease In memory of Dr. Mauro Rossi

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

Cervical screening. Cytology-based screening programmes

Largest efficacy trial of a cervical cancer vaccine showed Cervarix protects against the five most common cancercausing

March 28 th - 31 st Politecnico di Milano PRELIMINARY PROGRAMME

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

Final Program. 9 th Georg Rajka ISAD Program - Thursday, May 19, 2016 at the Renaissance São Paulo Hotel Theater

Guidelines for HPV vaccine

Dr. Unjali Malhotra Women s Health updates. Program Director UBC Women s Health Chair Canadian Foundation for Women s Health

PRELIMINARY PROGRAMME

What You Should Know. Exploring the Link between HPV and Cancer.

Arg-ADNI. Gustavo E. Sevlever, Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, Ricardo F. Allegri(*) and Arg-ADNI group.

International London Uropathology Conference 2014

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

HPV is the most common sexually transmitted infection in the world.

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

The HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health

COST Action CM1307 conference

NATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor 2017

Continuity of care heuristic model for sequential HPV testing over 3 tests with limited or extended genotyping

HPV Epidemiology and Natural History

Workshop Report: HPV and Cancer: Implications for Clinical Trials

BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM

Vaginal intraepithelial neoplasia (VaIN) is a rare

B2B Participation

Quick Reference: Immunization Communication Tool For Immunizers HPV 2010

What women should know about. cervical cancer. American Cancer Society Guidelines for the Early Detection of Cervical Cancer

HPV/Cervical Cancer Resource Guide for patients and providers

UICC HPV and CERVICAL CANCER CURRICULUM. UICC HPV and Cervical Cancer Curriculum Chapter 5. Application of HPV vaccines Prof. Suzanne Garland MD

Survey Responses to the EUROPEAN COCOA FORUM 2016

Transcription:

Latin American Human Papillomavirus Symposium 26-27 April 2018 Catholic Argentine University Auditorium Buenos Aires Argentina Preliminary Program Thursday, April 26 th 07:00 a 08:30 Registration 08:30-09:10 Opening Plenary Lecture - Nº 1: Chair: María Alejandra Picconi HPV as an etiologic agent for human cancer: the history of a major public health concern Silvia de Sanjosé 09:15-10:40 Round Table Nº 1: The biology of Human Papillomavirus (HPV) Chair: Daniela Gardiol * HPV Life Cycle Strategies and Disease John Doorbar * Relationship among HPV detection, the dynamics of the vaginal microbiota and the patient immune status in different age population settings. Patti Gravitt *An updated review of validated HPV detection methods for clinical application Jorge Basiletti 10:40-11:10 Break

11:10-12:55 Round Table Nº 2 A Critical Interpretation about the Screening for Cervical Cancer Prevention: Strengths and Weaknesses Chair: María Alejandra Picconi * HPV screening: role of systems thinking in implementation research. Patti Gravitt * HPV Detection in the Screening of Cervical Cancer: Trends and Innovations Rolando Herrero * Screening in Europe. Is this the model to be followed in Latin America? Silva de Sanjosé * HPV testing in primary screening: the Argentinian experience of the National Programme for Cervical Cancer Prevention Silvina Arrossi 13:00-14:30 Lunch break 14:30-16:15 Round Table Nº 3 HPV infection in other anatomical locations beyond the cervix Chair: Mariel Correa * New insights into HPV-induced lesions in the mouth Ricardo Sforza * Current focus on the oropharynx HPV-induced lesions Ricardo Marengo * New diagnostic and therapeutic algorithms in vulvar lesions Celeste Sluga * Natural history of HPV infection and pathogenesis in men Luisa Villa

* Progresses for the diagnosis and treatment of HPV-induced lesions of the anus Rita Pastore 16:15-16:45 Break 16:45-17:25 Plenary Lecture Nº 2 Chair: Juana Elida Mauro Evidence and Impact of Latent HPV Infections Patti Gravitt 17:30-18:30 Opening Ceremony Juana Elida Mauro y María Alejandra Picconi, Chairs of the Latin American Human Papillomavirus Symposium-2018 Artistic Event

Friday, April 27 th 08:30-09:10 Plenary Lecture Nº 3 Chair: Virginia Alonio The future of cervical cancer screening Luisa Villa 09:15-11:00 Round Table Nº 4 Novel Diagnostic and Therapeutic Approaches for Cervical HPV-Induced Lesions Chair: Andrés Humphreys * Biomarkers in Clinical Diagnosis John Doorbar * A renewed histology: the LAST classification Alejandra Maciel * Clinical convenience of HPV detection Fernando Monge * Electrosurgical excision in the treatment of SIL: When, why, where and who should be treated? Andrea Velazco 11:00-11:30 Break 11:30-12:55 Round Table Nº 5 A different look for a frequent clinical problem Chair: Alberto Santomé Osuna * Strategies for the condylomatosis in the lower genital tract Elida Mauro

* The use of immunomodulators: bringing a new perspective for treatment. Claudia Marchitelli * Current approach in the management for multicentric lesions Verónica Suzuki 13:00-14:30 Lunch Break 14:30-15:10 Plenary Lecture Nº 4 Chair: Juan Mural HPV test Screening and triage for the prevention of cervical cancer in Latin America. The ESTAMPA project: preliminary results" Rolando Herrero 15:15-15:55 Plenary Lecture Nº 5 Chair: Miguel Tilli The impact of HPV-induced diseases on the HIV-positive population Valeria Fink 16:00-16:30 Break 16:30 a 17:10 Plenary Lecture Nº 6 Chair: Alejandra Maciel HPV Tropisms and the Cellular Regulation of Neoplasia John Doorbar 17:15 a 19:00 Round Table Nº 6

Primary prevention of HPV infection and the associated diseases: current status and future prospects Chair: Diego Häbich * Efficacy, Effectiveness and Safety of HPV Licensed Vaccines Silvia de Sanjosé * Assessment of alternative HPV vaccination schedules: Would a single dose be sufficient? Rolando Herrero * Impact of the HPV prophylactic vaccination in the world Luisa Villa * Current Status of HPV Vaccination in Argentina: Outstanding Achievements and Challenges Nathalia Katz 19:05 a 19:30 Closing Ceremony Concluding Remarks